linjc16/ctgov huggingface dataset:
Prone Positioning vs. Prone Positioning and NO Inhalation in COVID-19 ARDS.

Study Overview
=================
Brief Summary
-----------------
The investigators aim to investigate the effects of prone positioning and prone positioning with NO inhalation for COVID-19 patients with ARDS.

Detailed Description
-----------------
The investigators aim to investigate the effects of prone positioning and prone positioning with NO inhalation for COVID-19 patients with ARDS. Patients with COVID-19-associated ARDS were ventilated in prone position with or without NO inhalation, the arterial blood gas (ABG) tests were performed at 16 hours after prone positioning.

Official Title
-----------------
Prone Positioning Versus Prone Positioning and NO Inhalation in COVID-19 Associated Acute Respiratory Distress Syndrome.

Conditions
-----------------
Respiratory Distress Syndrome

Intervention / Treatment
-----------------
* Drug: Nitric oxide
* Behavioral: prone positioning


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Adult patients with COVID-19 associated ARDS Exclusion Criteria: patients who have contraindication for prone positioning, including pregnant, post-abdomen surgery within a week; hypercapnic respiratory failure

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| patients ventilated in prone position<br>Patients ventilated in prone position | Behavioral: prone positioning<br>* vatilation in prone position<br>* Other names: PPV;|
| Patients ventilated in prone position with NO inhalation<br>Patients ventilated in prone position with NO inhalation | Drug: Nitric oxide<br>* Nitric oxide inhalation at 20 ppm<br>Behavioral: prone positioning<br>* vatilation in prone position<br>* Other names: PPV;|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| P/F ratio | P/F ratios in each group | 16 hours |
Reducing Anxiety Levels Through the Dharma Life App-Based and Mentor-Based Program Targeting Personality Characteristics: A Randomized Control Trial

Study Overview
=================
Brief Summary
-----------------
The purpose of this study was to examine whether an app- and mentor-based program reduced anxiety among individuals reporting difficulties with anxiety. For the intervention group, this study involved completing an 8-week program focused on helping participants reach their personality goals. The program involved app-based games, journaling, and completing behavioral challenges. Participants engaged with the study app for approximately 15 minutes per day and spoke with a study mentor weekly for 1 hour. Participants were asked to complete surveys prior to and after the program. The pre-program survey lasted approximately 1 hour, and the post-program survey lasted approximately 30 minutes. For the control group, this study involved completing surveys. Participants were asked to complete surveys 8 weeks apart. The first batch of surveys lasted approximately 1 hour, and the follow-up surveys lasted approximately 30 minutes.

Official Title
-----------------
Reducing Anxiety Levels Through the Dharma Life App-Based and Mentor-Based Program Targeting Personality Characteristics: A Randomized Control Trial

Conditions
-----------------
Anxiety

Intervention / Treatment
-----------------
* Behavioral: App


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Moderate to severe anxiety levels based on the BAI and GAD-7 Exclusion Criteria: We excluded participants experiencing any of the following self-reported behaviors in the past 6 months: substance abuse, self-harm, harm or destruction of another person or their property, suicidal ideations, and feeling helpless after the death of a loved one

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
Accepts Healthy Volunteers

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Treatment
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Experimental: App<br>Participants completed surveys at baseline and again after 8 weeks. Participants completed app-based games and consultation with a mentor over an 8 week period focused on alleviating anxiety. | Behavioral: App<br>* Participants completed games on an app and sessions with a mentor focused on alleviating anxiety over 8 weeks.<br>|
| No Intervention: Control<br>Participants completed surveys at baseline and again after 8 weeks. | |

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Beck Anxiety Inventory | Self report survey of anxiety symptoms | Baseline and after 8 weeks | 
| GAD-7 | Self report survey of anxiety symptoms | Baseline and after 8 weeks |
Evalution of Nurse's Abilities in ICU Setting

Study Overview
=================
Brief Summary
-----------------
The assessment of nurses' skills is of fundamental importance in order to predict their performance, this is true in all areas of care but especially in the critical area. The aim of the single center prospective observational study is to provide the organization and specifically the nursing coordinator with an evaluation form that is as specific and complete as possible for evaluating the performance of nurses in ICU. The nursing coordinators of 4 UOCs of intensive care for adults in the IRCCS Gemelli Polyclinic Foundation in Rome will be involved in the use of an evaluation scale for nurses. In each UOC, 10 nurses will be randomly selected for which to carry out the evaluation, subject to informed consent and compliance with the inclusion criteria in the study. Results Certify the reliability of the Scale for evaluating the performance and attitudes of nurses working in intensive care. It is hypothesized that an objective assessment tool of nurses' skills allows for an adequate allocation of resources not only in quantitative terms but also and above all in qualitative terms.

Official Title
-----------------
Evalution of Nurse's Specific Abilities in ICU Setting: Creation and Validation of a New Score

Conditions
-----------------
Assessment Tool of Nurses' Skills

Intervention / Treatment
-----------------
* Other: score


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Intensive care nurses present for at least 12 months in the relevant unit, Exclusion Criteria: Newly hired or newly transferred nurses (<12 months of presence in the relevant ICU).
Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
Accepts Healthy Volunteers

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Intervention/Treatment |
| --- |
|Other: score|Creation and validation of new nurse' score in ICU|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| evaluation the performance of nurse in ICU | Certify the reliability of the Scale for evaluating the performance and attitudes of nurses working in intensive care. | 2 years |
Modified Anterior Lamellar Recession for All Grades of Upper Eyelid Trachomatous Cicatricial Entropion

Study Overview
=================
Brief Summary
-----------------
This study aims to assess the combination of anterior lamellar recession (ALR) with blepharoplasty, suprasternal fixation, and internal eyelash bulb extirpation of aberrant lashes posteriorly located in patients with any grade of upper eyelid trachomatous cicatricial entropion

Official Title
-----------------
Modified Anterior Lamellar Recession for All Grades of Upper Eyelid Trachomatous Cicatricial Entropion

Conditions
-----------------
Entropion

Intervention / Treatment
-----------------
* Procedure: Modified anterior Lamellar Recession


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: All patients presented with upper lid trachomatous cicatricial entropion associated with rubbing lashes. Patients having a history of argon laser ablation, electrolysis, epilation, or past unsuccessful surgery were also included Exclusion Criteria: Patients with a follow-up period of fewer than 12 months. Patients with very severe UCE and required posterior lamellar grafts. Patients with etiology other than trachoma. Patients with dysplastic lashes without entropion were excluded

Ages Eligible for Study
-----------------
Minimum Age: 45 Years
Maximum Age: 60 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Treatment
Intervention Model: Single Group Assignment
Masking: None (Open Label)


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Experimental: Modified anterior Lamellar Recession<br>All patients in this arm underwent a combination of ALR, blepharoplasty, suprasternal fixation, and cauterization or internal bulb extirpation of posteriorly located lashes. | Procedure: Modified anterior Lamellar Recession<br>* ALR is one of the procedures used to treat cicatricial entropion and trichiasis. Few studies present the effect of modifications to this procedure in trachomatous entropion and trichiasis. Because trachoma is common in our country, there is a probability that the number of surgeries for TT will rise.<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Success rate | The cases will be considered succeed if there is no recurrence of the entropion | 3 months post operative | 
| Success rate | The cases will be considered succeed if there is no recurrence of the entropion | 6 months post operative | 
| Success rate | The cases will be considered succeed if there is no recurrence of the entropion | 9 months post operative | 
| Success rate | The cases will be considered succeed if there is no recurrence of the entropion | 12 months post operative |
Early Childhood Attention Battery in Preterm Children

Study Overview
=================
Brief Summary
-----------------
The aims of this project are: To explore, using the ECAB, if and in which measure the attentional abilities of young preterm children are different from term peers, whom reference data are already published27. To correlate the ECAB results with the Conner's Teacher, Rating Scale- Revised e Conner's Parent Rating Scale, one of the available diagnostic interview that helps to identify signs of Attention Deficit Hyperactivity Disorder (ADHD) in young children, at the age of 6 years and over. To study individual trajectories of attention pattern and development during age.

Official Title
-----------------
A Study on the Application of the Early Childhood Attention Battery in a Population of Preterms Children

Conditions
-----------------
Attention-deficit, Prematurity

Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: gestational age (GA) <34 weeks, intellectual functioning with Intelligence Quotient (IQ>70 verified with Wechsler scales performed within 6 months from the ECAB, age at ECAB assessment between 3 years and 5 years 11 months. Exclusion Criteria: presence of major brain lesions, major motor or behavioral disorders, WPPSI-III subtest receptive vocabulary with a scaled score <8.

Ages Eligible for Study
-----------------
Minimum Age: 42 Months
Maximum Age: 59 Months

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------
What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| attentional abilities of young preterm children | The Early Childhood Attention Battery (ECAB) consists of 8 subtest assessing 3 aspects of attention: selective attention, sustained attention, attentional control. Counting the number of correct answer we get a raw scores (with a different range for each task) that can be translated in a pondered score and in a percentile based on normative data collected on term born children and previously published | 3 years |
Uncontrolled Postviral Asthma and Persistent Symptoms After COVID-19

Study Overview
=================
Brief Summary
-----------------
Patients with long covid referred for physical rehabilitation at the Norwegian Sports Medicine Centre - Football Association in Oslo, Norway, were assessed for postviral asthma.

Detailed Description
-----------------
All patients performed methacholin bronchial provocation test, and those with a negative bronchial provocation were eqipped with an app-based spirometer to detect excessive lung variability. Eventual detection of postviral asthma will be treated according to GINA guidelines and eventual effect will be assessed by lung function variability and symptoms.

Official Title
-----------------
Uncontrolled Postviral Asthma in Patients With Long Covid

Conditions
-----------------
Long COVID

Intervention / Treatment
-----------------
* Diagnostic Test: App-based spirometer


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: ° Patients with long covid for more than 6 months referred for physical rehabilitation Exclusion Criteria: ° None

Ages Eligible for Study
-----------------
Minimum Age: 18 Years
Maximum Age: 70 Years

Sexes Eligible for Study
-----------------
All

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Intervention/Treatment |
| --- |
|Diagnostic Test: App-based spirometer|App-based spirometer to perform serial spirometry to assess lung function variatione|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Excessive lung function variation | Lung function given as FEV1. | 8 months | 
| Perceived symptoms of long covid | On a Likert scale 1-10 | 8 months | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
postviral asthma, diagnosis, long covid, telemedicine, lung function, digital spirometer
External Validation of Clinical Prediction Tools for Estimating Salt and Potassium Intake in Nephrology Patients.

Study Overview
=================
Brief Summary
-----------------
There is no validated self-questionnaire to assess salt and potassium intake in nephrology patients. Using Bayesian models, researchers developed clinical prediction tools to estimate salt and potassium intake in nephrology patients. These prediction tools performed well, with an accuracy of 89% for salt and 74% for potassium, and have undergone internal validation. Currently, the investigators wish to conduct an external validation study of these clinical prediction tools using data from patients followed at 3 nephrologic centers to generalize the performance results of the tools.

Official Title
-----------------
Multicenter External Validation of Clinical Prediction Tools for Estimating Salt and Potassium . Study UniverSel

Conditions
-----------------
Chronic Kidney Diseases

Intervention / Treatment
-----------------
* Other: administration questionary


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Male or female 18 years of age or older Consultant or inpatient in the nephrology department Having performed a 24-hour urinary assessment as part of his usual management with analysis of natriuresis and/or kaliuresis. Exclusion Criteria: Patient having lost salt by vomiting, diarrhea and intense sweating (sport) in the week preceding the 24-hour urine collection. Person protected by the french law

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| External validation a questionnaire<br>Questionnaire will be administrated to patient with chronic kidney diseases ti evaluated the consumption of salt and potassium intake. A Bayesian network and a multiple regression will be used to validated the questionary of 27 items | Other: administration questionary<br>* Questionnaire will be compared to 24h sodium and potassium urinary excretion (reference). A Bayesian network and a multiple regression will be used to validate the questionary<br>* Other names: administration questionary 27 items to evaluate the salt and potassium intake;|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| External multicenter validation questionary | comparison of answers to the questionnaire about salt and potassium diet with natriuresis and kaliuresis urinary excretion during 24 hours administrated in 3 centres in nephrology in France | at inclusion | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
salt diet, potassium diet, prediction tools, Bayesian network, kidney disease, epidemiology
abioSCOPE PSP Reference Range Study; Extension of AB-PSP-003

Study Overview
=================
Brief Summary
-----------------
This is a monocentric, prospective, biomarker-result-blinded observational study evaluating immunoassay measurements of pancreatic stone protein (PSP) performed on Abionic's abioSCOPE device with the PSP assay on generally healthy adults representative of the US population.

Official Title
-----------------
A Study to Establish a Reference Range for abioSCOPE® Device With the PSP Assay in a Generally Healthy Adult Population

Conditions
-----------------
Sepsis

Intervention / Treatment
-----------------
* Diagnostic Test: abioSCOPE


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Male or female, aged ≥ 18 years. Apparently healthy as determined by a subject questionnaire. Exclusion Criteria: Current diagnosis, or history, of any underlying major medical condition determined by the investigator, including but not limited to Renal disease Stoke Liver disease Pancreatic disease (including diabetes) HIV AIDS Receiving antibiotic therapy Suspected infection Immunosuppression Underwent procedures related to sepsis, or diagnosed with sepsis, within the last 12 months. Current diagnosis of uncontrolled diabetes. Diagnosis of bacterial, fungal, or malaria infection within the last 3 months that required antimicrobial treatment. Experienced severe trauma, surgery, cardiac arrest, or severe burn within the previous 3 months requiring medical care. Diagnosis and/or treatment of cancer within the last 12 months. Received immunosuppressive therapy. Hospitalization for more than 24 hours within the last month. Reported as currently pregnant or nursing a child Unable or unwilling to provide the required blood sample for testing.

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
Accepts Healthy Volunteers

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Intervention/Treatment |
| --- |
|Diagnostic Test: abioSCOPE|The abioSCOPE device with the PSP assay is intended to be indicated for ICU admitted patients at risk of developing sepsis. Results of abioSCOPE PSP assay may aid to identify sepsis in critically ill patients, together with all other clinical assessment and laboratory findings.|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| To determine the reference range intervals of PSP values measured using abioSCOPE device with the PSP assay in a generally healthy population representative of the US population. |  | through study completion, an average of 2 months |
Vulvar Disease in Nigeria Observational Study

Study Overview
=================
Brief Summary
-----------------
Vulvar disease in Nigeria A look at awareness within patients and health practitioners, self-reported and actual prevalence within communities in Nigeria

Official Title
-----------------
Vulvar Disease in Nigeria - Registry ( Observationsl Study)

Conditions
-----------------
Vulvar Diseases, Vulvar Atrophy, Dermatoses

Intervention / Treatment
-----------------
* Other: Observation


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: biological females - afab Exclusion Criteria: none-afab

Ages Eligible for Study
-----------------
Minimum Age: 10 Years
Maximum Age: 90 Years

Sexes Eligible for Study
-----------------
Female

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Intervention/Treatment |
| --- |
|Other: Observation|Observing for disease prevalence - actual and self-reported|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Prevalence of Vulvar disease | Awareness of Vulvar disease (descriptor) | 1-12 months |